ACUTE ADRENAL INSUFFICIENCY ASSOCIATED WITH HEPARIN-INDUCED THROMBOCYTOPENIA

REFERENCES

• Arepally GM, Ortel TL. Heparin-induced thrombocytopenia. N Engl J Med 2006; 355: 809–17.
   PubMed Web of Science ®Google Scholar
• Jang IK, Hursting MJ. When heparins promote thrombosis. Review of heparin-induced thrombocytopenia. Circulation 2005; 111: 2671–83.
   PubMed Web of Science ®Google Scholar
• Kelton JG. Heparin-induced thrombocytopenia: an overview. Blood Reviews 2002; 16: 77–80.
   PubMed Web of Science ®Google Scholar
• Ananthasubramaniam K, Shurafa M, Prasad A. Heparin-induced thrombocytopenia and thrombosis. Prog Cardiovasc Dis 2000; 42: 247–60.
   Web of Science ®Google Scholar
• Greinacher A, Farner B, Kroll H, Kohlman T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis: a retrospective analysis of 408 patients. Thromb haemost 2005; 94: 132–5.
   PubMed Web of Science ®Google Scholar
• Kurtz LE, Yang S. Bilateral adrenal hemorrhage associated with heparin-induced thrombocytopenia. Am J Hematol 2007; 82: 493–4.
   Web of Science ®Google Scholar
• Backaeen FG, Walkes JCM, Reardon MJ. Heparin-induced thrombocytopenia associated with bilateral adrenal hemorrhage after coronary artery bypass surgery. Ann Thoracic Surg 2005; 79: 1388–90.
   Web of Science ®Google Scholar
• Weyrich P, Balletshofer B, Hoeft S, Haring HU, Nawroth PP. Acute adrenocortical insufficiency due to heparin-induced thrombocytopenia with subsequent bilateral haemorrhagic infarction of the adrenal glands. Vasa 2001; 30: 285–8.
   Google Scholar
• Gaubet O, Pillet O, Cherifi A, Mayet T, Castaing Y, Favarel-Garrigues JC. Acute adrenal insufficiency due to bilateral adrenal hematoma following severe thrombopenia induced by lowmolecular-weight heparin. Presse Med 1999; 28: 1010–2.
   Web of Science ®Google Scholar
• Delhumeau A, Moreau X, Chapotte C, Houi N. Bigorgne JC. Heparin-associated thrombocytopenia syndrome: an underestimated etiology of adrenal hemorrhage. Intensive Care Med 1993; 19: 475–7.
   Web of Science ®Google Scholar
• Bleasel JF, Rasko JE, Rickard KA, Richards G. Acute adrenal insufficiency secondary to heparin-induced thrombocytopeniathrombosis syndrome. Med J Aust 1992; 157: 192–3.
   Web of Science ®Google Scholar
• Warkentin TE, Kelton JG, Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286–92.
   PubMed Web of Science ®Google Scholar
• Rice L, Attisha WK, Drexler A, Francis JL. Delayed-onset heparininduced thrombocytopenia. Ann Intern Med 2002; 136: 210–5.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Siragusa S, Girolami B, Fabris F. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study. Blood 2005; 106: 3049–54.
   PubMed Web of Science ®Google Scholar
• Menajovski LB. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med 2005; 118 (suppl 8A): 21S–30S.
   Google Scholar
• Kawashima A, Sandler CM, Ernst RD, et al. Imaging of nontraumatic hemorrhage of the adrenal gland. Radiographics 1999; 19: 949–63.
   PubMed Web of Science ®Google Scholar
• Vella A, Nippoldt TB, Morris JC. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc 2001; 76: 161–8.
   PubMed Web of Science ®Google Scholar
• Keeling D, Davidson S, Watson H. The management of heparininduced thrombocytopenia. Br J Haematol 2006; 133: 259–69.
   PubMed Web of Science ®Google Scholar
• Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. Chest 2004; 126: 311S–37S.
   Google Scholar
• Darling K, Jaumotte C, Saussoy P, Zech F, Lavenne E, Hainaut Ph. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by danaparoid sodium. Acta Clin Belg 2000; 55: 176–81.
   PubMed Web of Science ®Google Scholar
• Lubenow N, Warkentin TE, Greinacher A, et al. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical pratice during the 1990s. Thromb Res 2006; 117: 507–15.
   PubMed Web of Science ®Google Scholar
• Warkentin TE, Maurer BT, Aster RH. Heparin-induced thrombocytopenia associated with Fondaparinux. N Engl J Med 2007; 356: 2653–5.
   PubMed Web of Science ®Google Scholar